Literature DB >> 7830108

Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil.

A Abi-Dargham1, M Gandelman, S S Zoghbi, M Laruelle, R M Baldwin, P Randall, Y Zea-Ponce, D S Charney, P B Hoffer, R B Innis.   

Abstract

UNLABELLED: Iodine-123-iomazenil is a SPECT radiotracer used to image and quantify benzodiazepine receptors. The reproducibility of the measurement of benzodiazepine receptors in human brain with [123I]iomazenil and SPECT was investigated with a test/retest paradigm.
METHODS: Six subjects underwent two experiments during a 1-wk interval. Iodine-123-iomazenil was injected as a single bolus (12 mCi). The time-activity curves of the tracer in the arterial plasma were measured and corrected for metabolites. Regional time-activity curves of five brain regions were measured with the CERASPECT camera for 145 min postinjection with serial 2-min acquisitions. Data were analyzed using three kinetic models that included a two-compartment model, an unconstrained three-compartment model and a three-compartment model with a constraint on the nondisplaceable compartment.
RESULTS: The results from the various analyses and fitting strategies were compared. The variability (average absolute difference between test and retest, expressed as a percentage of the mean of both measurements) was 10% to 17%, depending on the outcome measure and the fitting procedure. The most reproducible outcome measure was the regional tracer distribution volume relative to the total arterial concentration (VT'). VT' showed an average regional variability of 10% +/- 2%, with an intraclass correlation coefficient of 0.81.
CONCLUSION: SPECT measurement of regional [123I]iomazenil VT' is reproducible and reliable. The use of regional ratios results in a significant loss of information.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7830108

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.

Authors:  Eunkyung Park; Jean-Dominique Gallezot; Aracely Delgadillo; Shuang Liu; Beata Planeta; Shu-Fei Lin; Kevin C O'Connor; Keunpoong Lim; Jae-Yun Lee; Anne Chastre; Ming-Kai Chen; Nicholas Seneca; David Leppert; Yiyun Huang; Richard E Carson; Daniel Pelletier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-02       Impact factor: 9.236

2.  Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET.

Authors:  David Elmenhorst; Philipp T Meyer; Andreas Matusch; Oliver H Winz; Karl Zilles; Andreas Bauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-23       Impact factor: 9.236

3.  3-Substituted 1,5-Diaryl-1 H-1,2,4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 2: Selection and Evaluation of [11C]PS13 for Quantitative Imaging.

Authors:  Stal Shrestha; Prachi Singh; Michelle Y Cortes-Salva; Kimberly J Jenko; Masamichi Ikawa; Min-Jeong Kim; Masato Kobayashi; Cheryl L Morse; Robert L Gladding; Jeih-San Liow; Sami S Zoghbi; Masahiro Fujita; Robert B Innis; Victor W Pike
Journal:  ACS Chem Neurosci       Date:  2018-06-13       Impact factor: 4.418

4.  Automatic Extraction of a Reference Region for the Noninvasive Quantification of Translocator Protein in Brain Using 11C-PBR28.

Authors:  Paolo Zanotti-Fregonara; William C Kreisl; Robert B Innis; Chul Hyoung Lyoo
Journal:  J Nucl Med       Date:  2019-01-17       Impact factor: 10.057

5.  A simple method for the quantification of benzodiazepine receptors using iodine-123 iomazenil and single-photon emission tomography.

Authors:  H Ito; R Goto; M Koyama; R Kawashima; S Ono; K Sato; H Fukuda
Journal:  Eur J Nucl Med       Date:  1996-07

6.  Sex-specific differences in GABA(A) -benzodiazepine receptor availability: relationship with sensitivity to pain and tobacco smoking craving.

Authors:  Irina Esterlis; Sherry A McKee; Kathryne Kirk; Dianne Lee; Frederic Bois; Stephanie M Stiklus; John P Seibyl; Suchitra Krishnan-Sarin; Stephanie S O'Malley; Julie K Staley; Kelly P Cosgrove
Journal:  Addict Biol       Date:  2012-02-21       Impact factor: 4.280

7.  Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: the optimal scan time.

Authors:  Y Onishi; Y Yonekura; F Tanaka; S Nishizawa; H Okazawa; K Ishizu; T Fujita; J Konishi; T Mukai
Journal:  Eur J Nucl Med       Date:  1996-11

8.  In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

Authors:  William C Kreisl; Chul Hyoung Lyoo; Meghan McGwier; Joseph Snow; Kimberly J Jenko; Nobuyo Kimura; Winston Corona; Cheryl L Morse; Sami S Zoghbi; Victor W Pike; Francis J McMahon; R Scott Turner; Robert B Innis
Journal:  Brain       Date:  2013-06-17       Impact factor: 13.501

9.  GABAA-benzodiazepine receptor availability in smokers and nonsmokers: relationship to subsyndromal anxiety and depression.

Authors:  Irina Esterlis; Kelly P Cosgrove; Jeffery C Batis; Frederic Bois; Tracy A Kloczynski; Stephanie M Stiklus; Edward Perry; Gilles D Tamagnan; John P Seibyl; Robert Makuch; Suchitra Krishnan-Sarin; Stephanie O'Malley; Julie K Staley
Journal:  Synapse       Date:  2009-12       Impact factor: 2.562

10.  PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects.

Authors:  Erica M Richards; Paolo Zanotti-Fregonara; Masahiro Fujita; Laura Newman; Cristan Farmer; Elizabeth D Ballard; Rodrigo Machado-Vieira; Peixiong Yuan; Mark J Niciu; Chul Hyoung Lyoo; Ioline D Henter; Giacomo Salvadore; Wayne C Drevets; Hartmuth Kolb; Robert B Innis; Carlos A Zarate
Journal:  EJNMMI Res       Date:  2018-07-03       Impact factor: 3.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.